Monographie - Amoxicillin sodium / clavulanic acid

Última actualização :
28/04/2024

Amoxicillin sodium / clavulanic acid

Estrutura química

Nomes comerciais nos diversos países

OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.

Aktil	Hungria
Amoclan	Arábia Saudita
Amoklavin	Turquia
Amoksiklav	Polonia
Amoxclav	Arábia Saudita
Amplamox	Brasil
Augmentin	Arábia Saudita, Austria, Bélgica, Chilli, Emirados Árabes Unidos, Equator, Espanha, França, Gran-bretanha, Grècia, Itália, Países Baixos, Polonia, Suicia, Turquia
Betamox	Portugal
Clavamox	Austria
Clavicin	Malásia, Venezuela
Clavulin	Brasil
Co-amoxi	Suicia
Co-Amoxicillin	Suicia
Curam	Arábia Saudita, Nova Zelândia
Darzitil	Argentina
Dibional	Argentina
Julmentin	Emirados Árabes Unidos
Novamox	Brasil
Sulbamox	Chilli
Tarometin	Polonia
Trifamox	Argentina, Colômbia, Equator, México

Bibliografía : Amoxicillin sodium / clavulanic acid

	Tipo	Publicação
186	Jornal	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
889	Jornal	Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM. Ofloxacin intravenous. Compatibility with other antibacterial agents. Pharm Weekbl [Sci] 1991 ; 13: 207-209.
1318	Jornal	Ashwin J, Lynn B, Taskis CB. Stability and administration of intravenous Augmentin. Pharm J 1987 ; 238: 116-118.
1357	Jornal	Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM. Quinolones and penicillins incompatibility. Ann Pharmacotherapy 1989 ; 23: 91-92.
1746	Jornal	Kambia N, Merite N, Dine T, Dupin-Spriet T, Gressier B, Luyckx M, Watinne C, Brunet C. Stability studies of amoxicillin/clavulanic acid combinaison in polyolefin infusion bags. EJHP 2010 ; 16, 30-37.
2139	Jornal	Serrurier C, Chenot ED, Vigneron J, May I, Demor? B. Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities. EJHP Science 2006 ; 12,5: 96-99.
2231	Jornal	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3520	Laboratório	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3529	Laboratório	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3545	Laboratório	Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit Mylan SAS 2009
3549	Laboratório	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Laboratório	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Laboratório	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3791	Poster	Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P. Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y. Apifh Congress, Paris November 2014 2014
3824	Jornal	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3948	Jornal	Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P . Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation. JPEN 2012 ;30. 416?424.
4470	Jornal	Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P. Continuous versus intermittent infusion of temocillin in intensive care unit patient. Critical care 2005 ; 9(Suppl 1) P37
4524	Poster	Stucki C, Sautter A-M, Bonnabry P. Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology. ESCP Symposium, Geneva, Switzerland 2009
4654	Poster	Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R. Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables. Communication personnelle 2021

Mentions Légales